Serum biomarkers for predicting microvascular complications of diabetes mellitus

Jiajia Wang Xiaoyi Song Ziqiao Xia Shu Feng Hangfeng Zhang Chengjie Xu Hui Zhang a Department of Laboratory Medicine,Sichuan Provincial People's Hospital,University of Electronic Science and Technology of China,Chengdu,Chinab Department of Laboratory Medicine,Sichuan Provincial People's Hospital Chuandong Hospital & Dazhou First People's Hospital,Dazhou,Chinac School of medicine,University of Electronic Science and Technology of China,Chengdu,Chinad Laboratory medicine,Qianwei People's Hospital,Leshan,Sichuan,Chinae Department of Ultrasound,Sichuan Provincial People's Hospital,University of Electronic Science and Technology of China,Chengdu,China
DOI: https://doi.org/10.1080/14737159.2024.2391021
2024-08-20
Expert Review of Molecular Diagnostics
Abstract:Introduction Diabetic microvascular complications such as retinopathy, nephropathy, and neuropathy are primary causes of blindness, terminal renal failure, and neuropathic disorders in type 2 diabetes mellitus patients. Identifying reliable biomarkers promptly is pivotal for early detection and intervention in these severe complications.
pathology
What problem does this paper attempt to address?